Philips Healthcare
Organisation
Trials
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
Collaborator, Phase 2, Active, not recruiting, 100 people, 14 Sept 2017
Sources: clinicaltrials.gov
Named in competing interests
Grants or research support, 13 Oct 2026
Employment, 12 Oct 2026
Fees or honoraria, 7 Sept 2026
Consulting or advice, Fees or honoraria, 18 Aug 2026
Charting brain morphology in international healthy and neurological populations
Employment, 29 Dec 2025
Employment, 25 Aug 2025
Sources: doi.org, pubmed.ncbi.nlm.nih.gov